Outcomes | Carvedilol | Placebo | RRR (95% CI) | NNT (CI) |
---|---|---|---|---|
‡Abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article. | ||||
All-cause mortality | 12% | 15% | 22% (3 to 38) | 30 (16 to 244) |
Cardiovascular mortality | 11% | 14% | 24% (4 to 40) | 29 (16 to 185) |
Non-fatal MI | 3% | 6% | 40% (9 to 60) | 44 (24 to 223) |
All-cause mortality or non-fatal MI | 14% | 20% | 27% (11 to 40) | 20 (12 to 52) |